Application | Comment | Organism |
---|---|---|
drug development | mycothiol cysteine ligase (MshC) is a promising target for developing anti-mycobacterial compounds | Mycobacterium tuberculosis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1,3,4,6-tetra-O-acetyl-2-deoxy-2-azido-D-glucopyranose | - |
Mycobacterium tuberculosis | |
1,3,4,6-tetra-O-acetyl-2-deoxy-2-fluoro-alpha-D-mannopyranose | - |
Mycobacterium tuberculosis | |
1,3,4,6-tetra-O-acetyl-2-deoxy-2-fluoro-D-glucopyranose | - |
Mycobacterium tuberculosis | |
1-D-myo-inositol 2-azido-2-deoxy-alpha-D-glucopyranoside | - |
Mycobacterium tuberculosis | |
1-D-myo-inositol 2-fluoro-2-deoxy-alpha-D-glucopyranoside | - |
Mycobacterium tuberculosis | |
2,3:4,5-di-O-cyclohexylidene-(1R)-menthyloxycarbonyl-D-myo-inositol | - |
Mycobacterium tuberculosis | |
2,3:4,5-di-O-cyclohexylidene-D-myo-inositol | - |
Mycobacterium tuberculosis | |
3,4,6-tri-O-acetyl-2-deoxy-2-azido-D-glucopyranose | - |
Mycobacterium tuberculosis | |
3,4,6-tri-O-acetyl-2-deoxy-2-azido-D-glucopyranosyl trichloroacetimidate | - |
Mycobacterium tuberculosis | |
3,4,6-tri-O-acetyl-2-deoxy-2-fluoro-D-glucopyranose | - |
Mycobacterium tuberculosis | |
3,4,6-tri-O-acetyl-2-deoxy-2-fluoro-D-glucopyranosyl trichloroacetimidate | - |
Mycobacterium tuberculosis | |
5'-O-(N-(L-cysteinyl)-sulfamoyl) dequalinium chloride adenosine | - |
Mycobacterium tuberculosis | |
6-O-benzyl-2,3; 4,5-di-O-cyclohexylidene-(1R)-menthyloxycarbonyl-D-myo-inositol | - |
Mycobacterium tuberculosis | |
6-O-benzyl-2,3; 4,5-di-O-cyclohexylidene-D-myo-inositol | - |
Mycobacterium tuberculosis | |
6-O-benzyl-O-(3,4,6-tri-O-acetyl-2-deoxy-2-azido-alpha-D-glucopyranosyl)-(1 <->1)-2,3:4,5-di-O-cyclohexylidene-D-myo-inositol | - |
Mycobacterium tuberculosis | |
6-O-benzyl-O-(3,4,6-tri-O-acetyl-2-deoxy-2-fluoro-alpha-D-glucopyranosyl)-(1<->1)-2,3:4,5-di-O-cyclohexylidene-D-myo-inositol | - |
Mycobacterium tuberculosis | |
dequalinium chloride | - |
Mycobacterium tuberculosis | |
additional information | the enzyme structure is critical to developing potential inhibitors, synthesis of substrate analogues as potential inhibitors for the MshC enzyme. Target molecules are synthesized employing a Schmidt glycosylation strategy using an enantiomerically pure inositol acceptor and 2-deoxy trichloroacetimidate glycosyl donors with glycosylation yields greater than 70% and overall yields over 5%. The inositol acceptor is obtained via chiral resolution of myo-inositol | Mycobacterium tuberculosis | |
NTF1836 | - |
Mycobacterium tuberculosis | |
O-(3,4,6-tri-O-acetyl-2-deoxy-2-fluoro-alpha-D-glucopyranosyl)-(1<->1)-2,3:4,5-di-O-cyclohexylidene-D-myo-inositol | - |
Mycobacterium tuberculosis |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Mycobacterium tuberculosis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol + L-cysteine + ATP | Mycobacterium tuberculosis | - |
1-O-[2-(L-cysteinamido)-2-deoxy-alpha-D-glucopyranosyl]-1D-myo-inositol + AMP + diphosphate | - |
? | |
1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol + L-cysteine + ATP | Mycobacterium tuberculosis ATCC 25618 / H37Rv | - |
1-O-[2-(L-cysteinamido)-2-deoxy-alpha-D-glucopyranosyl]-1D-myo-inositol + AMP + diphosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | P9WJM9 | - |
- |
Mycobacterium tuberculosis ATCC 25618 / H37Rv | P9WJM9 | - |
- |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol + L-cysteine + ATP = 1-O-[2-(L-cysteinamido)-2-deoxy-alpha-D-glucopyranosyl]-1D-myo-inositol + AMP + diphosphate | the mechanism of MshC has been proposed as bi-uni-uni-bi ping pong using steady state kinetics and positional isotope exchange studies. In the first phase of the enzymatic reaction, the nucleophilic attack of carboxylate of cysteine onto the phosphate of ATP leads to the formation of the cysteine-adenylate intermediate releasing inorganic diphosphate. This cysteine-adenylate intermediate is attacked by the amine of GlcN-Ins to form Cys-GlcN-Ins and in the process releases AMP, which completes the second phase of the enzymatic reaction, overview. During this stage, the reacting substrates and coenzymes are held in place by the amino acid residues W227, H55, T46, and D251 | Mycobacterium tuberculosis |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol + L-cysteine + ATP | - |
Mycobacterium tuberculosis | 1-O-[2-(L-cysteinamido)-2-deoxy-alpha-D-glucopyranosyl]-1D-myo-inositol + AMP + diphosphate | - |
? | |
1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol + L-cysteine + ATP | - |
Mycobacterium tuberculosis ATCC 25618 / H37Rv | 1-O-[2-(L-cysteinamido)-2-deoxy-alpha-D-glucopyranosyl]-1D-myo-inositol + AMP + diphosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
cysS2 | - |
Mycobacterium tuberculosis |
MshC | - |
Mycobacterium tuberculosis |
MTCY261.29c | - |
Mycobacterium tuberculosis |
mycothiol cysteine ligase | - |
Mycobacterium tuberculosis |
Rv2130c | - |
Mycobacterium tuberculosis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Mycobacterium tuberculosis |
General Information | Comment | Organism |
---|---|---|
metabolism | mycothiol cysteine ligase (MshC) is a key enzyme in the mycothiol (MSH) biosynthesis, mycothiol biosynthesis and metabolic pathway, overview | Mycobacterium tuberculosis |
physiological function | mycothiol cysteine ligase (MshC) is a key enzyme in the mycothiol (MSH) biosynthesis. The function of MshC is irreplaceable | Mycobacterium tuberculosis |